阿斯利康癌症药物推动利润增长
2026-07-27 06:19:38
据彭博社报道，阿斯利康公布的利润高于预期，主要受重磅癌症药物推动。市场现正关注该公司下一代肿瘤药物。
Disclaimer:
1. The information provided does not constitute investment advice. Investors should make independent decisions and bear all risks themselves.
2. The copyright of this content belongs to the original author. The views expressed herein are solely those of the author and do not represent the stance or position of this website.
Previous article：
罗兵咸永道倡延长港股时段
